Drug Topics
MARCH 12, 2024
The implementation of targeted educational interventions might improve knowledge gaps, which pose great risk to patients, in type 2 diabetes (T2D) management.
PharmaVoice
MARCH 12, 2024
As colorectal deaths rise among younger people, a diagnostic could help pinpoint more patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 12, 2024
In 2021, medical spending on pediatric mental health conditions accounted for 46.6% of all pediatric medical spending that year.
Pharmacy Times
MARCH 12, 2024
The cream significantly reduced abscesses and inflammatory nodules, reaffirming its efficacy as a maintenance option for HS.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 12, 2024
N-3 polyunsaturated fatty acids (PUFAs) are essential nutrients, especially during pregnancy as they support neurodevelopment in offspring and improve pregnancy outcomes.
STAT
MARCH 12, 2024
Over the past year, I have watched many children die of measles. In the final stages, little lungs, filled with fluid and racked with inflammation, struggle for oxygen. The victims breathe faster and faster, gasping for air until, exhausted, they stop.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 12, 2024
DETROIT — Every morning, Rebecca Smith, nursing a surgically repaired knee, carefully walks down the hallway of her brutalist brick apartment building, takes the elevator one floor to the lobby, and negotiates the sharply angled driveway outside. There, she waits for an Uber to take her to the last place she wants to go: her methadone clinic.
Pharmacy Times
MARCH 12, 2024
Integrate nutrition into the health care system with a proactive approach to chronic disease management
STAT
MARCH 12, 2024
The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient community hard. An earlier study had shown that patients who took the drug for six months experienced significantly less decline than people on the placebo in physical function, such as the ability to speak, use utensils, or climb stairs.
Fierce Healthcare
MARCH 12, 2024
Nashville, Tennessee-based patient engagement and payment technology company RevSpring has found itself with new investor ownership that promises to ramp up the business. | The patient engagement and payment technology company's new investor owner promised to bring "additional resources to accelerate and enhance RevSpring’s offerings.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MARCH 12, 2024
This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.
STAT
MARCH 12, 2024
The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week. The pill, called resmetirom, is made by Madrigal Pharmaceuticals. Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH , is often associated with obesity.
PharmaVoice
MARCH 12, 2024
Although a regulatory delay for Eli Lilly’s donanemab in Alzheimer’s disease is a competitive setback, researchers have their eye on better drug development as a result.
STAT
MARCH 12, 2024
WASHINGTON — In the last year, an estimated 11% of high school seniors have used Delta 8 THC, according to a new report published Tuesday in the Journal of the American Medical Association. Delta 8 THC is a quasi-legal psychoactive version of cannabis, which has skyrocketed in popularity after a loophole found in a 2018 federal law allowed it to be sold nationwide without the same restrictions placed on traditional marijuana.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
MARCH 12, 2024
Discover why gut bacteria are considered the next frontier in medicine in this informative article. Learn about the importance of the microbiome, its impact on health, and how it relates to conditions like Clostridiales difficile.
STAT
MARCH 12, 2024
Researchers at the University of California, Los Angeles have built a soft, adhesive patch capable of turning throat movements into speech. The patch, written about in a paper published in Nature Communications on Tuesday, is made out of a material that converts motion into electricity. This material, developed by the UCLA team in 2021, could be a gamechanger for sensors and wearables limited by their power sources.
Fierce Healthcare
MARCH 12, 2024
President Joe Biden's 2025 budget did not just touch upon cybersecurity, the drug price negotiation program and Medicare solvency, as the plan also suggested policy for mental health, health equity | Many significant policy items in Biden's proposed 2025 fiscal year budget don't grab the initial headlines, but he's looking to make strides in mental health, substance use disorder and maternal health.
Pharmacy Times
MARCH 12, 2024
Health span, wealth span, advocacy, and ethics are all burgeoning topics within the field of longevity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MARCH 12, 2024
The nation’s largest for-profit health systems reassured investors Tuesday that the Change Healthcare cyberattack, though disruptive in the short term, is a “transitory” event that’s unlikely to ha | Senior leadership at HCA Healthcare, Tenet Healthcare and Universal Health Systems say their organizations are shielded from the liquidity and administrative issues that are plaguing providers across the country.
Pharmacy Times
MARCH 12, 2024
Individuals included in the study reported positive changes in fatigue, and disease activity displayed endoscopic and histologic remission.
Fierce Healthcare
MARCH 12, 2024
ORLANDO — CodaMetrix, a company that provides automated coding technology for healthcare billing and revenue cycle management, picked up $40 million in fresh funding to build out its AI-based | odaMetrix, a company that provides automated coding technology for healthcare billing and revenue cycle management, picked up $40 million in fresh funding to build out its AI-based soultions.
pharmaphorum
MARCH 12, 2024
Discover the latest agency, consultancy, and investor hires from February 2024, including personnel from OVID Health, Avalere, WE Communications, and Eurozeo. Stay updated with industry movements and key players.
Pharmacy Times
MARCH 12, 2024
Although newly approved, there is some debate regarding the benefits and populations in which sotagliflozin will be the most effective.
pharmaphorum
MARCH 12, 2024
In the latest episode of the pharmaphorum podcast, host Nicole Raleigh speaks (virtually) with Nathan Clark, founder and CEO of Ganymede, a modern data platform and Cloud infrastructure for science, to discuss the evolving role of the Cloud in biopharma and some rather revolutionary tools in AI drug discovery.
Pharmaceutical Commerce
MARCH 12, 2024
A qualitative study explores how these drugs are impacting these patients’ lives, while digging deeper into the possibility of deprescribing, with insight from primary care physicians.
pharmaphorum
MARCH 12, 2024
Healthcare systems need to address the impact of racial and ethnic biases in the design and use of medical devices, says an independent UK review.
The Checkup by Singlecare
MARCH 12, 2024
Probiotics are known for their ability to help support a healthy gut microbiome, regulate digestion, improve stool patterns, and decrease gas and bloating. But if you’ve ever taken probiotic supplements, you’re likely aware of the potentially uncomfortable, to put it delicately, side effects of starting a new probiotic. With so many strains and varieties available for purchase, it’s hard to know which probiotics are right for you—and what’s normal to experience in the bathroom as your body adjus
pharmaphorum
MARCH 12, 2024
Up to 25,000 patients in England with ulcerative colitis are eligible for treatment with Pfizer’s Velsipity after NICE backed use of the drug on the same day as its MHRA approval.
Pharmaceutical Technology
MARCH 12, 2024
TERN-701 is a BCR-ABL tyrosine-kinase inhibitor being studied in a Phase I study, with data expected in H2 this year.
pharmaphorum
MARCH 12, 2024
Acadia Pharma has abandoned plans to develop Nuplazid for additional indications after the drug failed a phase 3 trial in schizophrenia.
Pharmaceutical Commerce
MARCH 12, 2024
A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.
pharmaphorum
MARCH 12, 2024
Sanofi says OX40L inhibitor amlitelimab could be a ‘best-in-class’ maintenance therapy for atopic dermatitis after reporting new phase 2b data
STAT
MARCH 12, 2024
Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry. While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.
Expert insights. Personalized for you.
307 
Let's personalize your content